TY - JOUR
T1 - Natural products, PGC-1α, and Duchenne muscular dystrophy
AU - Suntar, Ipek
AU - Sureda, Antoni
AU - Belwal, Tarun
AU - Sanches Silva, Ana
AU - Vacca, Rosa Anna
AU - Tewari, Devesh
AU - Sobarzo-Sánchez, Eduardo
AU - Nabavi, Seyed Fazel
AU - Shirooie, Samira
AU - Dehpour, Ahmad Reza
AU - Xu, Suowen
AU - Yousefi, Bahman
AU - Majidinia, Maryam
AU - Daglia, Maria
AU - D'Antona, Giuseppe
AU - Nabavi, Seyed Mohammad
N1 - Publisher Copyright:
© 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences
PY - 2020/5
Y1 - 2020/5
N2 - Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1α are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1α is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPARγ activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1α.
AB - Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1α are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1α is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPARγ activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1α.
KW - Mitochondrial oxidative phosphorylation
KW - Muscular dystrophy
KW - Natural product
KW - PPARγ activation
KW - Peroxisome proliferator-activated receptor γ coactivator 1α
KW - Reactive oxygen species
UR - https://www.scopus.com/pages/publications/85079816616
U2 - 10.1016/j.apsb.2020.01.001
DO - 10.1016/j.apsb.2020.01.001
M3 - Review article
AN - SCOPUS:85079816616
SN - 2211-3835
VL - 10
SP - 734
EP - 745
JO - Acta Pharmaceutica Sinica B
JF - Acta Pharmaceutica Sinica B
IS - 5
ER -